Skip to main
UHS
UHS logo

UHS Stock Forecast & Price Target

UHS Analyst Ratings

Based on 13 analyst ratings
Hold
Strong Buy 23%
Buy 15%
Hold 54%
Sell 8%
Strong Sell 0%

Bulls say

Universal Health Services Inc. has demonstrated a strong performance in its Acute Care Hospital Services segment, with same-store adjusted EBITDA margins expanding by 190 basis points to 15.8% and same-store revenue growth of 12.8%. The Behavioral Health Services segment also reported positive trends, with a 9.3% increase in same-store revenue and improved patient volumes contributing to a steady outlook for future growth. Additionally, anticipated benefits from pending CMS program approvals and a favorable operating environment suggest potential for revenue growth exceeding costs, bolstering a positive financial outlook for the company.

Bears say

The analysis indicates a negative outlook on Universal Health Services, driven by anticipated volume and margin headwinds that could result in earnings being approximately 5% below prior estimates for FY26. The company's behavioral health segment is projected to experience stagnant volume growth, with management adjusting its long-term outlook downward and potential EBITDA impacts from exchange subsidy decisions posing further challenges. Additionally, risks such as regulatory changes, high market concentration in Las Vegas, and tightening clinical labor supply are poised to exert additional pressure on productivity and margins, particularly impacting the firm's core business operations.

UHS has been analyzed by 13 analysts, with a consensus rating of Hold. 23% of analysts recommend a Strong Buy, 15% recommend Buy, 54% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Universal Health Services (UHS) Forecast

Analysts have given UHS a Hold based on their latest research and market trends.

According to 13 analysts, UHS has a Hold consensus rating as of Nov 4, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $230.69, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $230.69, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Universal Health Services (UHS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.